Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 948       

    Article Cited by others


Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use

Bhatnagar Tarun, Murhekar Manoj V, Soneja Manish, Gupta Nivedita, Giri Sidhartha, Wig Naveet, Gangakhedkar Raman

Year : 2020| Volume: 151| Issue : 2 | Page no: 184-189

   This article has been cited by
Samsun Saglik Bilimleri Dergisi. 2021; 6(1): 181
[Pubmed]  [Google Scholar] [DOI]
2 Role of Iron Chelation and Protease Inhibition of Natural Products on COVID-19 Infection
Giuseppe Carota,Simone Ronsisvalle,Federica Panarello,Daniele Tibullo,Anna Nicolosi,Giovanni Li Volti
Journal of Clinical Medicine. 2021; 10(11): 2306
[Pubmed]  [Google Scholar] [DOI]
3 Utilisation, Availability and Price Changes of Medicines and Protection Equipment for COVID-19 Among Selected Regions in India: Findings and Implications
Mainul Haque,Santosh Kumar,Jaykaran Charan,Rohan Bhatt,Salequl Islam,Siddhartha Dutta,Jha Pallavi Abhayanand,Yesh Sharma,Israel Sefah,Amanj Kurdi,Janney Wale,Brian Godman
Frontiers in Pharmacology. 2021; 11
[Pubmed]  [Google Scholar] [DOI]
4 Repositioning HIV protease inhibitors and nucleos(t)ide RNA polymerase inhibitors for the treatment of SARS-CoV-2 infection and COVID-19
Nils von Hentig
European Journal of Clinical Pharmacology. 2021;
[Pubmed]  [Google Scholar] [DOI]
5 Molecular Investigation of SARS–CoV-2 Proteins and Their Interactions with Antiviral Drugs
Paolo Calligari,Sara Bobone,Giorgio Ricci,Alessio Bocedi
Viruses. 2020; 12(4): 445
[Pubmed]  [Google Scholar] [DOI]
6 COVID-19 in India: Statewise Analysis and Prediction
Palash Ghosh,Rik Ghosh,Bibhas Chakraborty
JMIR Public Health and Surveillance. 2020; 6(3): e20341
[Pubmed]  [Google Scholar] [DOI]
7 Potential Drugs and Remedies for the Treatment of COVID-19: a Critical Review
Fatemeh Barati,Mahdi Pouresmaieli,Elena Ekrami,Sahar Asghari,Farzad Ramezani Ziarani,Matin Mamoudifard
Biological Procedures Online. 2020; 22(1)
[Pubmed]  [Google Scholar] [DOI]
8 Drug targets for COVID-19 therapeutics: Ongoing global efforts
Ambrish Saxena
Journal of Biosciences. 2020; 45(1)
[Pubmed]  [Google Scholar] [DOI]
9 COVID-19: Emergence, Spread, Possible Treatments, and Global Burden
Raghuvir Keni,Anila Alexander,Pawan Ganesh Nayak,Jayesh Mudgal,Krishnadas Nandakumar
Frontiers in Public Health. 2020; 8
[Pubmed]  [Google Scholar] [DOI]
10 Perspective on the Role of Antibodies and Potential Therapeutic Drugs to Combat COVID-19
Siddhi Tandon,Anchal Aggarwal,Shubhra Jain,Sanjay Shukla,Sarika Chaudhary
The Protein Journal. 2020; 39(6): 631
[Pubmed]  [Google Scholar] [DOI]
11 COVID-19 pandemic: Current scenario and our role
Vivek Kumar Bains
Asian Journal of Oral Health and Allied Sciences. 2020; 10: 1
[Pubmed]  [Google Scholar] [DOI]
12 The Rise and Impact of COVID-19 in India
S. Udhaya Kumar,D. Thirumal Kumar,B. Prabhu Christopher,C. George Priya Doss
Frontiers in Medicine. 2020; 7
[Pubmed]  [Google Scholar] [DOI]
13 Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19
Santosh Kumar,Kaining Zhi,Ahona Mukherji,Kelli Gerth
Viruses. 2020; 12(5): 486
[Pubmed]  [Google Scholar] [DOI]
14 SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments
Gisela Canedo-Marroquín,Farides Saavedra,Catalina A. Andrade,Roslye V. Berrios,Linmar Rodríguez-Guilarte,María C. Opazo,Claudia A. Riedel,Alexis M. Kalergis
Frontiers in Immunology. 2020; 11
[Pubmed]  [Google Scholar] [DOI]
15 COVID-19: Recent updates on SARS-CoV-2 and Preventing its Community Transmission in India by 21 Days Lockdown
Satyajeet K. Pawar,Shivaji T. Mohite
Journal of Pure and Applied Microbiology. 2020; 14(suppl 1): 921
[Pubmed]  [Google Scholar] [DOI]
16 COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments
Dieu-Donné Ouédraogo,Wendlassida Joelle Stéphanie Tiendrébéogo,Fulgence Kaboré,Honoré Ntsiba
Clinical Rheumatology. 2020; 39(7): 2069
[Pubmed]  [Google Scholar] [DOI]
17 COVID-19: Older drugs for a novel disease—Chloroquine, hydroxychloroquine, and possible Pentoxifylline—set to start the second innings?
Pugazhenthan Thangaraju,MeenalotchiniP Gurunthalingam,Shobanbabu Varthya,Sajitha Venkatesan,Eswaran Thangaraju
Journal of Family Medicine and Primary Care. 2020; 9(5): 2172
[Pubmed]  [Google Scholar] [DOI]
18 Risks to the community pharmacists and pharmacy personnel during COVID-19 pandemic: perspectives from a low-income country
B. Dzingirai,C. M. J. Matyanga,T. Mudzviti,M. Siyawamwaya,D. Tagwireyi
Journal of Pharmaceutical Policy and Practice. 2020; 13(1)
[Pubmed]  [Google Scholar] [DOI]
19 Overview of Early Cases of Coronavirus Disease 2019 (COVID-19) at a Tertiary Care Centre in North India
Shrikant Sharma,Prakash Keswani,Abhishek Bhargava,Ramji Sharma,Ajeet Shekhawat,Sudhir Bhandari
Annals of the Academy of Medicine, Singapore. 2020; 49(7): 449
[Pubmed]  [Google Scholar] [DOI]


Read this article